Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05554068
What this trial is testing

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Shingles
Loyola University 100
Early research (Phase 1)Study completedNCT03158896
What this trial is testing

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
University of Kansas Medical Center 24
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT07670468
What this trial is testing

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
BKV InfectionEBV InfectionCMV Infection
LucasBio 27
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Not applicableStudy completedNCT02194868
What this trial is testing

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Assistance Publique - Hôpitaux de Paris 57
Not applicableStudy completedNCT03079089
What this trial is testing

Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

Who this might be right for
Refractory or Relapsed Lymphoid Haemopathy
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40
Testing effectiveness (Phase 2)Study completedNCT01203020
What this trial is testing

Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation

Who this might be right for
Hodgkin's LymphomaNon-Hodgkin's Lymphoma
West Virginia University 22
Testing effectiveness (Phase 2)Study completedNCT00496340
What this trial is testing

Phase II Trial of Pentostatin and Targeted Busulfan

Who this might be right for
Hematologic Malignancies
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Looking for participantsNCT07565220
What this trial is testing

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Who this might be right for
Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Acute Leukemia+2 more
Sawa Ito, MD 48
Early research (Phase 1)Ended earlyNCT00373815
What this trial is testing

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
University Hospital Tuebingen 10
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Not applicableUnknownNCT03806764
What this trial is testing

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient

Who this might be right for
Cytomegalovirus InfectionsHaematological MalignancyOrgan or Tissue Transplant; Complications+1 more
Melbourne Health 370
Post-approval studies (Phase 4)UnknownNCT03150134
What this trial is testing

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Who this might be right for
Acute Myeloid LeukemiaDisorder Related to Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableNot Yet RecruitingNCT07703657
What this trial is testing

Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationEpstein-Barr Virus ReactivationClinically Significant EBV DNAemia
Yang Donglin 168
Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Early research (Phase 1)Ended earlyNCT03151057
What this trial is testing

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

Who this might be right for
B Cells-TumorsB Cell Chronic Lymphocytic LeukemiaFollicular Lymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Testing effectiveness (Phase 2)Ended earlyNCT01050764
What this trial is testing

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Who this might be right for
Leukemia, AcuteChronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)+4 more
Everett Meyer 10
Testing effectiveness (Phase 2)Study completedNCT05009719
What this trial is testing

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Who this might be right for
Hematologic Malignancy
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Next Page